Overview

Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset

Status:
Completed

Trial end date:
2017-12-11

Target enrollment:

Participant gender:

Summary

To evaluate the safety and efficacy of alteplase when administered between 3 and 4.5 hours after onset of stroke symptoms in Chinese patients with acute ischemic stroke

Phase:

Phase 3

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Tissue Plasminogen Activator